AAAAAA
Results: 1-25/109
Authors:
Soussi, T
Citation: T. Soussi, Cancer, genetic stability and repair of DNA: Convergence or divergence, EUROCANCER 98, 1998, pp. 3-4
Authors:
Berger, R
Citation: R. Berger, Rearrangement of genes in acute leukemia, EUROCANCER 98, 1998, pp. 5-6
Authors:
Golstein, P
Citation: P. Golstein, Programmed cell death: Recent progress, EUROCANCER 98, 1998, pp. 7-8
Authors:
Burger, AM
Citation: Am. Burger, Telomerase, EUROCANCER 98, 1998, pp. 11-12
Authors:
Pignon, JP
Bourhis, J
Domenge, C
Designe, L
Armand, JP
Luboinski, B
Citation: Jp. Pignon et al., Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): loco-regional treatment versus same treatment plus chemotherapy, EUROCANCER 98, 1998, pp. 15-16
Authors:
Poupon, MF
Citation: Mf. Poupon, Predictive factors of cancer chemosensitivity, EUROCANCER 98, 1998, pp. 17-18
Authors:
Kvalheim, G
Citation: G. Kvalheim, Detection and quantification of residual disease in bone marrow and PBPC, EUROCANCER 98, 1998, pp. 19-21
Authors:
De Roquancourt, A
Citation: A. De Roquancourt, Ductal cancer of the breast, EUROCANCER 98, 1998, pp. 25-26
Authors:
Lidereau, R
Citation: R. Lidereau, Breast cancer in situ: Somatic genetics, EUROCANCER 98, 1998, pp. 27-28
Authors:
Feger, C
Citation: C. Feger, Imaging of breast cancer in situ, EUROCANCER 98, 1998, pp. 29-30
Authors:
Silverstein, MJ
Citation: Mj. Silverstein, Surgical aspects of ductal carcinoma in situ, EUROCANCER 98, 1998, pp. 31-32
Authors:
Pouillart, P
Citation: P. Pouillart, Is in situ cancer sensitive to non-surgical treatment?, EUROCANCER 98, 1998, pp. 33-33
Authors:
Holmberg, L
Warnberg, F
Bergh, J
Citation: L. Holmberg et al., Risk factors for breast cancer death and subsequent invasive carcinomas after a primary breast carcinoma in situ of the breast, EUROCANCER 98, 1998, pp. 35-36
Authors:
Bonte, J
Citation: J. Bonte, Progesterone replacement therapy in the patient treated for breast cancer, EUROCANCER 98, 1998, pp. 39-40
Authors:
Hupperets, PS
Coombes, CR
Wils, JA
Marty, M
Citation: Ps. Hupperets et al., Chemotherapy induced menopause: risk according to age and type of treatment, EUROCANCER 98, 1998, pp. 41-42
Authors:
Espie, M
Perret, F
Citation: M. Espie et F. Perret, Risks of early menopause and their assessment, EUROCANCER 98, 1998, pp. 43-44
Authors:
Brettes, JP
Matheilin, C
Gairard, B
Citation: Jp. Brettes et al., Hormone replacement therapy and impact on breast cancer, EUROCANCER 98, 1998, pp. 45-46
Authors:
Christiansen, C
Citation: C. Christiansen, New approaches in osteoporosis prevention: bisphosphonates and SERMs, EUROCANCER 98, 1998, pp. 47-48
Authors:
Vassiloupoulou-Sellin, R
Citation: R. Vassiloupoulou-sellin, Hormone replacement therapy after breast cancer: available evidence from retro and prospective studies, EUROCANCER 98, 1998, pp. 49-50
Authors:
Gorins, A
Cremieu, A
Espie, M
Perret, F
Tournand, B
Marty, M
Citation: A. Gorins et al., Hormone replacement therapy in menopausal women with a history of breast cancer, EUROCANCER 98, 1998, pp. 51-52
Authors:
Bourhis, J
Citation: J. Bourhis, Transfer of gene p53 for modification of the radiotherapy response, EUROCANCER 98, 1998, pp. 55-56
Authors:
Le Floch, O
Citation: O. Le Floch, Irradiation of cancer: How to treat tumors and preserve function, EUROCANCER 98, 1998, pp. 57-59
Authors:
Bosset, JF
Magnin, V
Baron, MH
Lorchel, F
Mineur, L
Citation: Jf. Bosset et al., Adjuvant radiotherapy of rectal cancer: Modes, indications, perspectives, EUROCANCER 98, 1998, pp. 61-64
Authors:
Bey, P
Aletti, P
Citation: P. Bey et P. Aletti, Conformational radiotherapy. Perspectives: Intensity modulation, EUROCANCER 98, 1998, pp. 65-66
Authors:
Gerard, JP
Roy, P
Cuchera, P
Citation: Jp. Gerard et al., Radiotherapy for primary cancer - Indispensable approach for cures, EUROCANCER 98, 1998, pp. 69-71